GILD and CVS Related Headlines
Go Back- Gilead stock falls after CVS holds off adding HIV prevention shot to plans
- BMO Capital on Gilead Sciences (GILD): 'Expect GILD shares to be weaker on this announcement'
- CVS Health (CVS) not yet adding Gilead's Yeztugo to its commercial or ACA plans - Reuters
- Exclusive-CVS holds off adding Gilead’s new HIV prevention shot to drug coverage lists
